Study of the Psychological Factors Influencing Post-traumatic Growth During Oncological Pathway
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Centre Hospitalier de Valenciennes
- Enrollment
- 289
- Locations
- 1
- Primary Endpoint
- Post-traumatic growth
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients over 18 years of age
- •Patients in the initial phase of curative treatment for a 1st solid cancer
- •At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course)
- •At less than 6 months from the initial diagnosis
- •Patient having given written consent to participate in the study
Exclusion Criteria
- •Patients with a previous history of cancer
- •Patients with incurable cancer progression, recurrence or relapse
- •Metastatic, brain, hematological or skin cancer
- •Patients who have difficulty understanding written French
- •Patient psychologically or physically unable to answer questionnaires
Outcomes
Primary Outcomes
Post-traumatic growth
Time Frame: T3 : 6 months after the end of chemotherapy protocol
Post-traumatic growth will be assessed using a 21-item self-report questionnaire and a Likert scale ranging from 0 (Not at all) to 4 (Totally), the Posttraumatic growth inventory (PTGI), which has been revalidated in French (Dubuy et al., 2022) in 4 dimensions: new direction for life (6 items), personal abilities (6 items), spiritual change (2 items) and relationships with others (7 items).
Secondary Outcomes
- Satisfaction of supportive care needs(T3 : 6 months after the end of chemotherapy protocol)
- Anxiety and depression symptoms(T3 : 6 months after the end of chemotherapy protocol)
- Psychological flexibility(T3 : 6 months after the end of chemotherapy protocol)
- Emotional competence(T3 : 6 months after the end of chemotherapy protocol)